Technology Transfer Fee. Within […***…] of the Effective Date, CRISPR shall pay to EC a non-creditable, non-refundable, one-time technology transfer fee of CHF […***…].
Appears in 2 contracts
Sources: License Agreement (CRISPR Therapeutics AG), License Agreement (CRISPR Therapeutics AG)